This low coverage of male-biased genes in the whole body data was also observed in Anopheles gambiae[ 6, 22].
When shorter imaging times are preferred, fewer slices may be acquired to cover the entire body – as in a recently reported approach in which 10-mm-thick image slices were acquired every 40 mm of the whole body, but only 20% of the full body data was captured.
The whole-body data were therefore used to calculate the total body residence time and also formed the basis for the kinetics of the urinary bladder contents.
Different publications provided different levels of detail for body size measurement, and consequently, the body size data were separated into two categories: mean body size ('mean') and body size range ('range'range
Initial body weight and body length data were obtained at the beginning of the growth trial.
The body weight data were analysed to test the claim that dapagliflozin does not affect body weight (ie, no weight gain).
No body anthropomorphic data were collected to define the theoretical absolute zero point of the abdomen.
All δ13C and δ15N, body length data were examined with a Mann–Whitney's U test using the Excel software to evaluate differences between sites and seasons.
Sex, weight, condition, dentition, and body measurement data were collected for each animal.
For all analyses, body size data were log10 transformed and a length-frequency distribution was computed from these data.
Body weight data were analyzed by the PROC Mixed procedure of SAS for day 21 (BW were not different at day 15).
